Table: Kyorin Holdings -2020/21 group results

Kyorin Pharmaceutical

17/05/2021 01:00

May 17 (Reuters)- 
          Kyorin Holdings Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT    
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022      YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY    
                 RESULTS         RESULTS       FORECAST     H1 FORECAST  
  Sales          102.90          109.98         102.60         47.30     
               (-6.4 pct)      (-3.2 pct)                                
  Operating        5.79            7.50           3.30      loss 800 mln 
               (-22.9 pct)     (-16.4 pct)                               
  Recurring        6.45            8.18           3.80      loss 600 mln 
               (-21.1 pct)     (-13.4 pct)                               
  Net
  Net              6.13            6.15           2.70      loss 300 mln 
               (-0.3 pct)      (-10.5 pct)                               
  EPS          106.99 yen      107.35 yen      47.12 yen   loss 5.24 yen 
  Ann Div       75.00 yen       75.00 yen      52.00 yen                 
  -Q2 Div       30.00 yen       30.00 yen      20.00 yen                 
  -Q4 Div       45.00 yen       45.00 yen      32.00 yen                 
  
  NOTE - Kyorin Holdings Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T